期刊文献+

肝硬化肠道细菌移位与多器官组织病理功能变化的关系探讨 被引量:2

Relationship of bacterial translocation with histological injury and dysfunction of multiple organ in liver cirrhosis model
下载PDF
导出
摘要 目的探讨肝硬化(LC)肠道细菌移位(BT)与多器官组织病理及功能变化的相关性。方法 40只雄性SD大鼠,鼠龄3个月左右,体质量(250±20)g。随机分为对照组(NC组,10只)、肝硬化模型组(LC组,30只)。LC组采用改造的复合病因诱导大鼠LC模型,将肠系膜淋巴结匀浆进行细菌培养,以细菌培养结果分为BT阳性组和BT阴性组;留取股动脉血检测肝、肾功能及血氨;行肝、回肠、肾、脑组织病理学检测(苏木精-伊红染色)。结果成功复制了LC大鼠模型。NC组大鼠未发生BT;LC组大鼠细菌移位,阳性率为69.23%,其中大部分为大肠埃希氏细菌(88.9%)。BT阳性组血清白蛋白及血氨水平分别显著低于和高于BT阴性组(均P<0.05)。与BT阴性组比较,BT阳性组有更为显著的肝、脑及回肠组织病理改变。结论BT是LC常见的病理生理变化,其发生与肠道屏障功能减弱、明显的肝功能减弱、潜在增加的发生肝性脑病的可能性相关。 Objective To investigate the effects of bacterial translocation(BT) on vital organs in liver cirrhosis(LC), and determine the relationship between BT and vital organs. Methods Forty male SD rats, aged 3-months old, body weight (250± 20) g, which were randomly divided into 2 groups: control group(NC, n = 10) and LC group(n = 30). LC group was rat cirrhosis model induced by composite etiology pathogenic factors, and the mesenteric lymph node homogenates was cultured for bacterial amplification. The animals were subsequently divided into BT positive group(BT+) and BT negative group(BT-) accordances with the bacterial culture results. Blood specimens were collected from femoral artery for the detection of hepatic function, renal function and ammonia(AMM). Tissue sections of liver, ileum, kidney, and brain were prepared for histological examination (HE staining). Results The LC model was successfully induced. The bacterial translocation was not observed in NC group, whereas the translocation rate in LC group was 69.23 %, most of which were E.coli bacteria(88.9 %). Compared with the BT+ group, the BT- group showed significantly increased serum level of albumin and decreased serum level of AMM(P 〈 0.05). The pathological changes in liver, ileum and brain tissue of the BT+ group were worse than that in the BT- group(P 〈 0.05). Conclusion It is demonstrated that BT is a common pathophysiological change in LC, it could influence liver function and may increase the possibility of occurrence of hepatic encephalopathy.
出处 《生物医学工程与临床》 CAS 2012年第5期477-481,F0003,共6页 Biomedical Engineering and Clinical Medicine
基金 贵州省科学技术基金资助(黔科合J字[2008]2285号)
关键词 肝硬化 细菌移位 肝性脑病 肝肾综合征 liver cirrhosis bacterial translocation hepatic encephalopathy hepatorenal syndrome
  • 相关文献

参考文献16

  • 1Yan AW, Fouts DE, Brandl J, et oi. Enteric dysbiosis associated with a mouse model of alcoholic liver disease [J]. Hepatology, 2011, 53(1): 96-105. 被引量:1
  • 2吴仲文,徐凯进,李兰娟,左键,盛吉芳,郑树森,梁廷波,沈岩,王伟林,张珉.78例肝硬化患者肠道细菌易位及其相关性研究[J].中华外科杂志,2006,44(21):1456-1459. 被引量:16
  • 3Guo Y, Wang H, Zhang C. Establishment of rat precision-cut fi- brotic liver slice technique and its application in verapamil met- abolism [J]. Clin Exp Pharmacol Physiol, 2007, 34 (5-6): 406- 413. 被引量:1
  • 4李伟.胸腺肽α1对肝硬化大鼠肠细菌转位及小肠Toll—likeReceptor4表达的影响[J].上海:复旦大学,2006. 被引量:1
  • 5陈江,陈玉满,夏勇,章荣华,蔡德雷,郑云燕,严峻.大鼠肝纤维化复合模型的建立及动态观察[J].中国卫生检验杂志,2010,20(3):547-550. 被引量:6
  • 6向贤宏,李家平,陈柳琴,谭国胜,陈伟,杨建勇,李鹤平.大鼠肝硬化模型制备的改良[J].当代医学,2009,15(35):729-731. 被引量:7
  • 7王强,杨婷,刘伟新,罗维.传统肝硬化动物模型制备方法的改良[J].中国初级卫生保健,2005,19(3):84-85. 被引量:1
  • 8Teltschik Z, Wiest R, Beisner J, et ol. Intestinal bacterial translo- cation in rats with cirrhosis is related to compromised Paneth c- ell antimicrobial host defense[J]. Hepatology, 2012, 55(4): 1154- 1163. 被引量:1
  • 9Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut[J]. J Physiol, 2012, 590(Pt 3): 447-458. 被引量:1
  • 10Sekirov I, Russell SL Antunes LC, et ol. Gut microbiota in heal- th and disease[J]. Physiol Rev, 2010, 90(3): 859-904. 被引量:1

二级参考文献55

  • 1陈波,何生.肝纤维化动物模型的建立[J].华西医学,2005,20(4):796-797. 被引量:13
  • 2吴仲文,李兰娟.肝硬化并发症与肠道菌群[J].国际流行病学传染病学杂志,2006,33(1):34-37. 被引量:10
  • 3韩德五 马学惠 等.肝硬化动物模型的研究[J].山西医药杂志,1979,(1):1-1. 被引量:92
  • 4Hung DY, Chang P, Cheung K, et al. Quantitative evaluation of altered hepatic spaces and membrane transport in flbrofie rat liver[ J]. Hepatolegy,2002,36(5 ) : 1180 - 1189. 被引量:1
  • 5Roderfeld M, Geier A, Dietrich CG, et al. Cytokine blockade inhibits hepatic tissue inhibitor of metalloproteinase - 1 expression and up - regulates matrix metalloproteinase - 9 in toxic liver injury [ J ]. Liver Int,2006,26(5) :579 -586. 被引量:1
  • 6Kitamura Y, Ninomiya H. Smad expression of hepatic stellate cells in liver cirrhosis in vivo an d hepatic stellate cell line in vitro[J]. Pathol Int,2003,53 (2) :18 -26. 被引量:1
  • 7Nagase H. Zinc metallopmteinases in health and disease [ M ]. Taylor and Franices London, 1996 : 153 - 204. 被引量:1
  • 8Watanabe T, Niioka M, Ishikawa A, et al. Dynamic change of cells expressing MMP - 2 mRNA and MTI - MMP mRNA in the recovery from liver fibrosis in the rat[ J]. J Hepatol,2001,35 (4) :465 -473. 被引量:1
  • 9El -Gindy l,El Rabnum AT,El -Alim MA,et al. Diagnostic potential of serunl matrix metalloproteinase - 2 an d tissue inhibitor of metalioproteinase - 1 as non - invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease[ J]. Egypt J Immunol,2003,10 (1) :127 -35. 被引量:1
  • 10Lero YV, Monier F, Bottaris S, et al. Circulating matrix metalloproteinases 1,2,9 and their inhibitors TIMP - 1 and TIMP - 2 as serum markers of liver fibrosis in patients with chronic hepatitis C : comparison with PII - INP and hyaluronic acid [ J ]. Am J Gastroenterol, 2004,99(2) :271 -279. 被引量:1

共引文献27

同被引文献36

  • 1Robin Arora,Shweta Kathuria,Nishant Jalandhara.Acute renal dysfunction in patients with alcoholic hepatitis[J].World Journal of Hepatology,2011,3(5):121-125. 被引量:4
  • 2Sekirov I, Russell SL, Caetano L, Antunes M, Finlay BB. Gut microbiota in health and disease. Physiol Rev,2010,90:859-904. 被引量:1
  • 3Clemente JC, Ursell LK, Parfrey LW, Knight R, The impact of the gut nficrobiota on human health:an integrative view. Cell ,2012,148:1258- 1270. 被引量:1
  • 4Quigley EMM, Stanton C, Murphy EF. The gut microbiota and the liver. Pathophysiological and clinical implications. J Hepatology 2013, ht- tp ://dx. doi. org/10. 1016/j. jhep. 2012.11. 023. 被引量:1
  • 5Compare D, Coccoli P, Rocco A, et al. Gut-liver axis : the impact of gut microbiota on non alcoholic fatty liver disease. Nutrition Metabolism & Cardiovascular Disease, 2012,22:471-476. 被引量:1
  • 6Clarridge JE, et al. Impact of 16S rRNA gene sequence analysis for i- dentification of bacteria on clinical microbiology and infectious disea- ses. Clin Microbiot Rev, 2004,17:840-862. 被引量:1
  • 7Gomez-Hurtado I, Santacruz A, Peiro G, et al. Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CC14-induced fibrosis. J Hepatol,2011,54:245-245. 被引量:1
  • 8Chen Y,Yang F, Lu H,Lei D, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology, 2011,54:562- 572. 被引量:1
  • 9Steed H, Macfarlane GT, Blackett KL, Macfarlane S, et al. Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota. FEMS hnmunology & Medical Microbiology, 2011,63: 346-354. 被引量:1
  • 10Sanchez E, Casafont F, Guerra A,et at. Role of intestinal bacterial over- growth and intestinal motility in bacterial translocation in experimental cirrhosis. Rev Esp Enferm Dig ,2005,97:805-814. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部